Farther Finance Advisors’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.1K Buy
782
+11
+1% +$257 ﹤0.01% 3901
2026
Q1
$14.9K Hold
771
﹤0.01% 3853
2025
Q4
$18.6K Buy
771
+52
+7% +$1.36K ﹤0.01% 3501
2025
Q3
$18.3K Buy
719
+32
+5% +$759 ﹤0.01% 3106
2025
Q2
$14.8K Sell
687
-652
-49% -$14.7K ﹤0.01% 2857
2025
Q1
$30.6K Sell
1,339
-254
-16% -$6.69K ﹤0.01% 2153
2024
Q4
$41.4K Sell
1,593
-337
-17% -$8.39K ﹤0.01% 1758
2024
Q3
$48.3K Sell
1,930
-3,699
-66% -$87.4K ﹤0.01% 1687
2024
Q2
$117K Buy
5,629
+5,243
+1,358% +$102K 0.01% 1067
2024
Q1
$6.91K Buy
386
+4
+1% +$70 ﹤0.01% 1920
2023
Q4
$6.21K Buy
+382
New +$4.87K ﹤0.01% 1854

Other funds holding BLFS

Farther Finance Advisors's BLFS Position: Q2 2026 in Review

Farther Finance Advisors increased its BioLife Solutions (BLFS) stake by 1.4% in Q2 2026, buying an estimated $257 and bringing the position to 782 shares worth $22.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3901.

Farther Finance Advisors first reported a position in BLFS in Q4 2023 and has held it in 11 quarters since. The position peaked at $117K in Q2 2024. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Farther Finance Advisors held 782 shares of BioLife Solutions worth $22.1K as of Q2 2026.
  • Farther Finance Advisors bought 11 BioLife Solutions shares in Q2 2026, an estimated $257.
  • BioLife Solutions made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3901 holding.
  • Farther Finance Advisors first reported a position in BioLife Solutions in Q4 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's BioLife Solutions position peaked at $117K in Q2 2024.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.